Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To demonstrate that the combination of FOLFIRI plus sunitinib is superior to FOLFIRI plus placebo in prolonging the progression-free survival (PFS) in the first-line treatment of patients with metastatic colorectal cancer.
Inclusion criteria
- first-line treatment of patients with metastatic colorectal cancer